Patrick O'Brien - 21 Dec 2022 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role
General Counsel
Signature
/s/Patrick O'Brien
Issuer symbol
ARWR
Transactions as of
21 Dec 2022
Net transactions value
+$196,800
Form type
4
Filing time
22 Dec 2022, 19:01:04 UTC
Previous filing
07 Jan 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARWR Common Stock Options Exercise $196,800 +32,000 +9.2% $6.15* 380,875 21 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARWR Stock Option (right to buy Common Stock) Options Exercise $0 -32,000 -100% $0.000000* 0 21 Dec 2022 Common Stock 32,000 $6.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying Restricted Stock Units granted to the reporting person which are subject to certain vesting conditions.
F2 Represents the first vesting date. Option vested over four years from date of grant.